Vanda Pharmaceuticals (VNDA) Non-Current Deferred Tax Liability (2014 - 2017)

Vanda Pharmaceuticals' Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at -$386000.0 for Q4 2017.

• In Q4 2017, Non-Current Deferred Tax Liability fell 157.96% year-over-year to -$386000.0; the TTM figure through Dec 2017 stood at -$386000.0 (down 157.96% YoY), while the FY2017 annual figure was -$386000.0, down 157.96% from the prior year.
• Non-Current Deferred Tax Liability came in at -$386000.0 for Q4 2017 at Vanda Pharmaceuticals, down from $666000.0 in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 million in Q4 2015 to a low of -$386000.0 in Q4 2017.
• A 4-year average of $346500.0 and a median of $336000.0 in 2014 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability soared 18233.33% in 2015 and sank 157.96% in 2017, its largest moves.
• Vanda Pharmaceuticals' Non-Current Deferred Tax Liability stood at $6000.0 in 2014, then jumped by 18233.33% to $1.1 million in 2015, then tumbled by 39.45% to $666000.0 in 2016, then slumped by 157.96% to -$386000.0 in 2017.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered -$386000.0, $666000.0, and $1.1 million for Q4 2017, Q4 2016, and Q4 2015 respectively.

Peer Comparison